Business Segments · Goodwill
Oncology & Multispecialty — Goodwill
McKesson Oncology & Multispecialty — Goodwill increased by 0.3% to $3.96B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 45.5%, from $2.72B to $3.96B.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2024
Last reportedQ4 2026May 8, 2026
Rolls up toGoodwill
How to read this metric
A stable or increasing balance suggests successful integration and sustained value, while a decrease may indicate impairment testing results.
Detailed definition
This metric represents the carrying value of goodwill allocated to the Oncology and Multispecialty segment, arising from...
Peer comparison
Standard balance sheet item for companies with significant M&A activity in the specialty pharmacy and healthcare services space.
Metric ID:
mck_segment_oncology_multispecialty_goodwillHistorical Data
5 periods
| Q4 '24 | Q4 '25 | Q2 '26 | Q3 '26 | Q4 '26 | |
|---|---|---|---|---|---|
| Value | $2.78B | $2.72B | $3.93B | $3.95B | $3.96B |
| QoQ Change | — | -1.8% | +44.2% | +0.6% | +0.3% |
| YoY Change | — | -1.8% | — | — | +45.5% |
Range$2.72B – $3.96B
CAGR+42.8%
Avg YoY Growth+21.8%
Median YoY Growth+21.8%
Current Streak3 quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is McKesson's oncology & multispecialty — goodwill?
- McKesson (MCK) reported oncology & multispecialty — goodwill of $3.96B in Q1 2026.
- How has McKesson's oncology & multispecialty — goodwill changed year-over-year?
- McKesson's oncology & multispecialty — goodwill increased by 45.5% year-over-year, from $2.72B to $3.96B.
- What does oncology & multispecialty — goodwill mean?
- The total value of goodwill attributed to the Oncology and Multispecialty segment from past acquisitions.